Page last updated: 2024-10-26

3,3'-diindolylmethane and Laryngeal Neoplasms

3,3'-diindolylmethane has been researched along with Laryngeal Neoplasms in 1 studies

3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research Excerpts

ExcerptRelevanceReference
"Diindolylmethane seems to have no adverse affects on the rat even when given in doses 3x what we propose to be therapeutic."1.35A controlled safety study of diindolylmethane in the immature rat model. ( Elackattu, AP; Feng, L; Wang, Z, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elackattu, AP1
Feng, L1
Wang, Z1

Other Studies

1 other study available for 3,3'-diindolylmethane and Laryngeal Neoplasms

ArticleYear
A controlled safety study of diindolylmethane in the immature rat model.
    The Laryngoscope, 2009, Volume: 119, Issue:9

    Topics: Animals; Body Weight; Feasibility Studies; Indoles; Kidney; Laryngeal Neoplasms; Liver; Models, Anim

2009